NEW BRUNSWICK, N.J.—At a meeting with the investment community, members of Johnson & Johnson’s executive committee and leaders from the Innovative Medicine and MedTech businesses highlighted the company’s overarching strategy, its Innovative Medicine and MedTech pipelines and long-term financial outlook.
Read more...